Labs in Court

Subscribe today for access to
Articles and Reports

By Danielle Sloane, Morgan Tandy | Oct 28, 2024 | 1 min read

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

By Karen Lovitch, Jane Haviland | Jul 24, 2024 | 1 min read

COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action

By Glenn S. Demby | Jul 31, 2023 | 1 min read

Last month’s key cases involved the outcome of a UHC lawsuit and fines for misleading claims about a COVID-19 test.

By Glenn S. Demby | Jul 4, 2023 | 1 min read

Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.

By Glenn S. Demby | May 31, 2023 | 1 min read

In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.

By Glenn S. Demby | Jan 27, 2023 | 1 min read

In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.